Bevacizumab chemotherapy for pulmonary epithelioid hemangioendothelioma with severe dyspnea

J Thorac Oncol. 2011 Mar;6(3):651-2. doi: 10.1097/JTO.0b013e31820b9e23.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Brain Neoplasms / complications
  • Brain Neoplasms / pathology*
  • Dyspnea / diagnosis*
  • Dyspnea / etiology
  • Female
  • Hemangioendothelioma, Epithelioid / diagnosis
  • Hemangioendothelioma, Epithelioid / drug therapy*
  • Hemangioendothelioma, Epithelioid / etiology
  • Humans
  • Lung Neoplasms / diagnosis*
  • Lung Neoplasms / etiology
  • Lymphatic Metastasis
  • Middle Aged
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab